Kavitha Mudaliar @KavithaMudali

🧬🔬Renal biopsy says amyloidosis… what next? This brilliant IHC-based algorithm 🔁 guides you through AL, AA, & rare amyloid types—don’t miss that dual diagnosis! 🔗 doi.org/10.1159/000545… 🆕 Dr @VinitaSGPGIMS et. al #RenalPath #Amyloidosis #Nephrology #MedTwitter

Fantastic talk by @BasuGopal at @GlomCon on Post-Transplant GN. Check out the management summary. His slides were pure gold 😍

C3GN is classified as “Ultra rare “ Yet we Nephrologists debate on it True to the definitions Generalist knows less and less about more and more until he knows nothing about everything A specialist knows more and more about less and less until he knows everything about nothing”

🫘✅Hyperkalemia Management 😎Potassium binders ✅Sodium Polystyrene sulphate ✅Patiromer ✅Sodium Zirconium cyclosilicate @NDTsocial @hjanders_hans academic.oup.com/ndt/advance-ar…

Cirrhosis & Kidney: A Dangerous Duo AKI→ AKD→ CKD isn’t just renal; it’s hepatic too Up to 50% with cirrhosis develop AKI & upto 25% may progress to CKD Spot it early, act fast #NephTwitter #Nephrology #Hepatology #MedEd #Cirrhosis #AKI #CKD 🔗dx.doi.org/10.5527/wjn.v1… 🆕 🆓

🔅Podocytopathies : case based review 🦠The podocyte is a critical component of the glomerular filtration barrier. Injury to these specialized cells results in podocytopathies. 🏥These diseases can have variable clinical presentations and biopsy features, which will help…

keyboard_arrow_left Previous keyboard_arrow_right Next

😳Myths with Furosemide ❌Furosemide is contraindicated in AKI-Its not ✅Indicated in AKI with fluid overload

Gopambuj Singh Rathod @IamGopambuj

5 months ago

😳Myths with Furosemide ❌Furosemide is contraindicated in AKI-Its not ✅Indicated in AKI with fluid overload

0 21 72 11K 33

Download Image

We are familiar with this name. We have all used the catheters designed by this genius, but we know very little about the person. I write about Dr Mahurkar in the just-released bulletin of @NephKarnataka @krithicism @arvindcanchi @sundar_s1955 @snamratarao @Nair_Sanj

💡 Who should get #Tolvaptan in #ADPKD? A stepwise approach to identifying rapid disease progression 📈 ✔️ eGFR decline >3 ml/min/yr? Treat! ✔️ Imaging/genetic risk? Assess! 📊 @BMCNephrology 🔗 doi.org/10.1186/s12882… #Nephrology #Kidney #NephTwitter

Parvo B19 and kidney Key notes #ParvoB19 #transplant #infections @AnnaGaddy @dakidneydoc @DocGaggar @dr_sourabha @dra_miliflores @happiedoc @hardik4u24 @drpriyajohn @myadla @elbaonelida

Hyperkalemia management: practice points in potassium control 🍌 @goKDIGO @NephJC

👍New Lupus Nephritis guidelines #ACR2024 🤘Major change-Triple therapy for induction ✅

🌟Beyond Testing—IgAN Trials Unveiled!-Must Read🌟 From #Sparsentan to #Iptacopan, innovative non-immunomodulatory & immunomodulatory therapies are transforming IgAN care!🎯 🔬 Excellent Trial insights by @Melgreux 📖 via @KidneyKolumns Jan25 #Nephrology #IgAN #ClinicalTrials

We are pleased to announce the publication of the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Read the news release: kdigo.co/2025-ADPKD-Gui… This first-ever KDIGO guideline focused…

keyboard_arrow_left Previous keyboard_arrow_right Next

💊BP lowering in CKD 1️⃣Step-ACEi/ARB+CCB/thiazide diuretic 2️⃣Step-ACEi/ARB +CCB+ Thiazide diuretic 3️⃣Step-Add Beta blocker/Spironolactone/central acting agent @NDTsocial @hjanders_hans doi.org/10.1093/ndt/gf…

🎯🫘ANCA Vasculitis -One infographic summary of KDIGO guideline @KidneyKolumns @goKDIGO Infographic @happiedoc

Print this and put it up in the wards 😍 Credits: unknown #MedTwitter

Diagnostic approach to the patient with kidney cysts from @fouadchebib #Nephpearls #RKDC

🔥Approach to Hypercalcemia @AJKDonline core curriculum